HEXAGYN® uno
Vaginal capsules with hyaluronic acid
HEXAGYN® uno, vaginal capsules, are a medicinal product with hyaluronic acid, which has a role in the treatment of vaginal dryness. It provides hydration and promotes the renewal of the vaginal mucosa. It has a soothing effect and eliminates discomfort caused by age-related vaginal dryness or estrogen deficiency, e.g. as a consequence of menopause.
• HEXAGYN® uno, vaginal capsules restore natural vaginal moisture in conditions of vaginal dryness, atrophy and dystrophy.
• the hyaluronic acid mixture contained in the product ensures the formation of a layer on the surface of the mucous membrane, which encourages the regeneration of the vaginal epithelium
• creates appropriate conditions for activating natural regenerative mechanisms / restores the ability of the mucous membrane to activate physiological repair processes during healing. It creates a natural barrier that prevents the development of pathogenic flora, restores natural moisture and accelerates the healing process.
Indications
HEXAGYN® uno, vaginal capsules:
• to relieve complaints associated with dryness of the vaginal mucosa, symptoms of pain, irritation, burning, itching or swelling of the vagina and vaginal lips;
• during menopause and in the postmenopausal period – to reduce discomfort caused by dryness of the vagina associated with age or lack of estrogen;
• in conditions of atrophy or dystrophy of the vaginal epithelium, it moisturizes and creates optimal conditions for the physiological regeneration of the vaginal mucosa;
• for moisturizing and protecting the vaginal mucosa and alleviating the symptoms of inflammatory conditions caused by the use of contraceptives, hormone replacement therapy (HRT), systemically applied glucocorticoids, diabetes medications;
• to restore proper lubrication of the mucous membrane, and thus the physiological function and regeneration ability of the vaginal mucosa after operations, childbirth and laser therapy or radiation therapy;
• as a lubricant to reduce pain during sexual activity
Contraindications and precautions
• capsules are intended for local use in the vagina, do not swallow them and avoid contact with the eyes;
• do not use if the package is damaged or after the expiration date stated on the label;
• do not use if there is any disturbing local reaction (in the intimate area) such as eczema, redness and swelling;
• do not use if you are allergic to any of the product’s ingredients;
• do not use this product with other vaginal products, including medical products, or seek medical advice. There are no known interactions with other medicinal products or medicinal products;
• do not use during menstruation and in case of acute infection, seek the advice of a doctor;
• do not use with latex condoms;
• keep out of reach of children
Use only in accordance with the instructions for use
The use of HEXAGYN® uno, vaginal capsules in pregnant and lactating women requires medical approval due to the lack of data on studies in this population.
Method of use
The capsule removed from the inner packaging should be inserted deep into the vagina, taking care not to leave any pieces of protective film on the surface of the capsule.
• Standard therapy: 1 capsule per day, in the evening before going to bed for 7-14 days or according to the doctor’s instructions.
• Additional therapy: 1 vaginal capsule at night every 3 days or according to the doctor’s instructions to maintain a lubricated vaginal mucosa.
The product can be used for up to 30 days.
Use only internally, topically in the vagina. Wash your hands well before and after use.
Store in a well-closed package, in a dry place, away from light and heat sources, at a temperature of up to 25 °C.
Ingredients: low molecular weight hyaluronic acid (LMW) 5mg as sodium hyaluronate, high molecular weight hyaluronic acid (HMW) 5mg as sodium hyaluronate. Auxiliary substances: semi-synthetic glycerides.
It does not contain hormones, vegetable oils or extracts and fragrances.
A small box containing two blister packs, 10 vaginal capsules of 2 g each.
Registration number: 515-02-00220-22-004 from August 8, 2022